Gotham Asset Management’s Lucid Diagnostics LUCD Stock Holding History
Bought
Maintained
Sold
Other funds holding LUCD
MCM
TSC
AIC
GCM
PCM
Gotham Asset Management's LUCD Position: Q3 2025 in Review
Gotham Asset Management sold out of Lucid Diagnostics (LUCD) in Q3 2025, closing a stake of 14,886 shares — an estimated $136K sold.
Gotham Asset Management first reported a position in LUCD in Q4 2024 and held it in 3 quarters. The position peaked at $140K in Q1 2025. 86 funds tracked by Wall St. Rank hold LUCD as of Q3 2025.
- Gotham Asset Management reported no remaining Lucid Diagnostics position as of Q3 2025 after selling out during the quarter.
- Gotham Asset Management sold 14,886 Lucid Diagnostics shares in Q3 2025, an estimated $136K.
- Gotham Asset Management first reported a position in Lucid Diagnostics in Q4 2024 and held it in 3 quarters.
- Gotham Asset Management's Lucid Diagnostics position peaked at $140K in Q1 2025.
- 86 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2025.
Based on Gotham Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.